Sensitivity of human herpesvirus 6 and other human herpesviruses to the broad-spectrum antiinfective drug artesunate

Journal of Clinical Virology

Volumn 46, Issue 1, 2009, Pages 24-28

  Milbradt, Jens ^a   Auerochs, Sabrina ^a   Korn, Klaus ^a   Marschall, Manfred ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Antiviral activity; Artemisinin; Artesunate; Epstein Barr virus; Human cytomegalovirus; Human herpesvirus 6

Indexed keywords

ARTESUNATE; ETOPOSIDE; GANCICLOVIR; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIVIRAL ACTIVITY; ANTIVIRAL SUSCEPTIBILITY; APOPTOSIS; ARTICLE; CELL STRAIN; CONTROLLED STUDY; DRUG CYTOTOXICITY; EPSTEIN BARR VIRUS; HERPES VIRUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 6; IC 50; IMMUNOFLUORESCENCE; INHIBITION KINETICS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; VIRUS GENOME; VIRUS REPLICATION; WESTERN BLOTTING;

ANTIVIRAL AGENTS; ARTEMISININS; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HERPESVIRIDAE; HUMANS; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; PLAQUE ASSAY; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 67949095831     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2009.05.017     Document Type: Article

References (33)

1. Caserta M.T., Mock D.J., and Dewhurst S. Human herpesvirus 6. Clin Infect Dis 33 (2001) 829-833
2. De Bolle L., Naesens L., and de Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 18 (2005) 217-245
3. Portolani M., Pecorari M., Tamassia M.G., Gennai W., Beretti F., and Guaraldi G. Case of fatal encephalitis by HHV-6 variant A. J Med Virol 65 (2001) 133-137
4. Zerr D.M. Human herpesvirus 6: a clinical update. Herpes 13 (2006) 20-24
5. Zerr D.M., Gooley T.A., Yeung L., Huang M.L., Carpenter P., Wade J.C., et al. Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients. Clin Infect Dis 33 (2001) 763-771
6. Isaacson E., Glaser C.A., Forghani B., Amad Z., Wallace M., Armstrong R.W., et al. Evidence of human herpesvirus 6 infection in 4 immunocompetent patients with encephalitis. Clin Infect Dis 40 (2005) 890-893
7. Tavakoli N.P., Nattanmai S., Hull R., Fusco H., Dzigua L., Wang H., et al. Detection and typing of human herpesvirus 6 by molecular methods in specimens from patients diagnosed with encephalitis or meningitis. J Clin Microbiol 45 (2007) 3972-3978
8. Cermelli C., Berti R., Soldan S.S., Mayne M., D'ambrosia J.M., Ludwin S.K., et al. High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection. J Infect Dis 187 (2003) 1377-1387
9. Donati D., Akhyani N., Fogdell-Hahn A., Cermelli C., Cassiani-Ingoni R., Vortmeyer A., et al. Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology 61 (2003) 1405-1411
10. Birnbaum T., Padovan C.S., Sporer B., Rupprecht T.A., Ausserer H., Jaeger G., et al. Severe meningoencephalitis caused by human herpesvirus 6 type B in an immunocompetent woman treated with ganciclovir. Clin Infect Dis 40 (2005) 887-889
11. Harma M., Loginov R., Piiparinen H., Halme L., Hockerstedt K., and Lautenschlager I. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation. Transplant Proc 37 (2005) 1230-1232
12. Efferth T., Romero M.R., Wolf D.G., Stamminger T., Marin J.J.G., and Marschall M. The antiviral activities of artemisinin and artesunate. Clin Infect Dis 47 (2008) 804-811
13. Adjuik M., Babiker A., Garner P., Olliato P., Taylor W., and White N. International Artemisinin Study Group. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363 (2004) 9-17
14. Ribeiro I.R., and Olliaro P. Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials. Med Trop 58 (1998) 50-53
15. De Vries P.J., and Dien T.K. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs 52 (1996) 818-836
16. Gomes M., Ribeiro I., Warsame M., Karunajeewa H., and Petzold M. Rectal artemisinins for malaria: a review of efficacy and safety from individual patient data in clinical studies. BMC Infect Dis 8 (2008) 39
17. Efferth T., Marschall M., Wang X., Huong S.M., Hauber I., Olbrich A., et al. Antiviral activity of artesunate towards wild-type, recombinant and ganciclovir-resistant human cytomegaloviruses. J Mol Med 80 (2002) 233-242
18. Kaptein J.F., Efferth T., Leis M., Rechter S., Auerochs S., Kalmer M., et al. The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo. Antiviral Res 69 (2006) 60-69
19. Efferth T., Dunstan H., Sauerbrey A., Miyachi H., and Chitambar C.R. The anti-malarial artesunate is also active against cancer. Int J Oncol 18 (2001) 767-773
20. Efferth T., Benakis A., Romero-Rodriguez M., Steinbach D., Häfer R., Stamminger T., et al. Enhancement of cytotoxicity of artemisinins towards cancer cells by ferrous iron. Free Radicals Biol Med 37 (2004) 998-1009
21. Milbradt J., Auerochs S., and Marschall M. Cytomegaloviral proteins pUL50 and pUL53 are associated with the nuclear lamina and interact with cellular protein kinase C. J Gen Virol 88 (2007) 2642-2650
22. Aberle S.W., and Puchhammer-Stöckl E. Diagnosis of herpesvirus infections of the central nervous system. J Clin Virol 25 (2002) 79-85
23. Yoshikawa T., Asano Y., Akimoto S., Ozaki T., Iwasaki T., Kurata T., et al. Latent infection of human herpesvirus 6 in astrocytoma cell line and alteration of cytokine synthesis. J Med Virol 66 (2002) 497-505
24. Crumpacker C.S. Ganciclovir. N Engl J Med 335 (1996) 721-729
25. Bork P.M., Schmitz L.M., Kuhnt M., Escher C., and Heinrich M. Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-κB. FEBS Lett 402 (1997) 85-90
26. Siedle B., Garcia-Pineres A.J., Murillo R., Schulte-Mönting J., Castro V., Rüngeler P., et al. Quantitative structure-activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-κB. J Med Chem 47 (2004) 6042-6054
27. Efferth T., Sauerbrey A., Olbrich A., Gebhart E., Rauch P., Weber H.O., et al. Molecular modes of action of artesunate in tumor cell lines. Mol Pharmacol 64 (2003) 382-394
28. Wagner S., Hofmann A., Siedle B., Terfloth L., Merfort I., and Gasteiger J. Development of a structural model for NF-kappaB inhibition of sesquiterpene lactones using self-organizing neural networks. J Med Chem 49 (2006) 2241-2252
29. McGready R., Ashley E.A., Moo E., Cho T., Barends M., Hutagalung R., et al. A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy. J Infect Dis 192 (2005) 846-853
30. Gordi T., and Lepist E.I. Artemisinin derivatives: toxic for laboratory animals, safe for humans?. Toxicol Lett 147 (2004) 99-107
31. Shapira M.Y., Resnick I.B., Chou S., Neumann A.U., Lurain N.S., Stamminger T., et al. Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation. Clin Infect Dis 46 (2008) 1455-1457
32. Schmidt B., Ashlock B., Neipel F., and Levy J.A. Potential screening assay for undetectable viruses on the basis of their capacity to induce alpha interferon production. J Clin Microbiol 42 (2004) 4300-4302
33. Iyengar S., Levine P.H., Ablashi D., Neequaye J., and Person G.R. Sero-epidemiological investigations on human herpesvirus 6 (HHV-6) infections using a newly developed early antigen assay. Int J Cancer 49 (1991) 551-557